Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 5/20 | 0.57 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.57 |
| ▸ | SORT1 | Q99523 | 5/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.56 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2549331 | 1.00 | NTSR2 (0.57) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| SCHEMBL29886800 | 0.90 | NTSR2 (0.67) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| SCHEMBL30436277 | 0.88 | NTSR1 (0.60) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| SCHEMBL31738532 | 0.87 | NTSR1 (0.76) | NTSR2NTSR1SORT1 | |
| SCHEMBL32664435 | 0.87 | NTSR2 (0.58) | NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL31114540 | 0.86 | OPRM1 (0.64) | NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL31114390 | 0.86 | OPRM1 (0.64) | NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL29517091 | 0.86 | OPRM1 (0.54) | NTSR2NTSR1SORT1OPRM1 | |
| SCHEMBL31692757 | 0.86 | NTSR2 (0.53) | NTSR2NTSR1SORT1OPRM1OPRK1 | |
| SCHEMBL30906006 | 0.86 | NTSR1 (0.57) | NTSR2NTSR1SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2114462-B1 | Compounds for fluorescence imaging | UNIV GENEVE (CH) | 2013-06-05 | — | — | EP | disclosed |
| US-20110263975-A1 | FLUORESCENT PROBES HAVING A POLYMERIC BACKBONE | GE HEALTHCARE AS (NO) | 2011-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263975-A1 | FLUORESCENT PROBES HAVING A POLYMERIC BACKBONE | CD38, ARFGAP1, ADCYAP1R1 | NTSR2 1072/4885NTSR1 794/4885SORT1 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.